Add to my selection

GLYBERA (alipogène tiparvovec)

Medicine - Posted on Jan 28 2016 - Updated on Jun 12 2019

Active substance (DCI)

alipogène tiparvovec

history (1)

11/4/15

GLYBERA (alipogene tiparvovec), gene therapy

Insufficient clinical benefit because of the moderate, heterogeneous and unsustained effect on the blood triglyceride level ...

icône flèche

Technical information

ATC code

C10AX10

Manufacturer

CHIESI SA

Presentation

GLYBERA 3x10^12 copies du génome/ml, solution injectable (code CIS : 69001649) flacon(s) en verre de 1 ml - Code CIP : 3400958676437

All our publications

Congenital, genetic and rare diseases

Pancreatic and biliary tract diseases